Search by Drug Name or NDC

    NDC 55513-0369-55 Otezla Details

    Otezla

    Otezla is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amgen Inc. The primary component is .

    Product Information

    NDC 55513-0369
    Product ID 55513-369_3e8d8499-e557-4e75-8655-554a1a2d0b04
    Associated GPIs 6670001500B720
    GCN Sequence Number 073370
    GCN Sequence Number Description apremilast TAB DS PK 10-20-30MG ORAL
    HIC3 S2Z
    HIC3 Description ANTI-INFLAMMATORY,PHOSPHODIESTERASE-4(PDE4) INHIB.
    GCN 37765
    HICL Sequence Number 040967
    HICL Sequence Number Description APREMILAST
    Brand/Generic Brand
    Proprietary Name Otezla
    Proprietary Name Suffix n/a
    Non-Proprietary Name apremilast
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Amgen Inc
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA205437
    Listing Certified Through 2024-12-31

    Package

    NDC 55513-0369-55 (55513036955)

    NDC Package Code 55513-369-55
    Billing NDC 55513036955
    Package 1 BLISTER PACK in 1 CARTON (55513-369-55) / 1 KIT in 1 BLISTER PACK
    Marketing Start Date 2020-02-26
    NDC Exclude Flag N
    Pricing Information N/A